STARD7
Basic information
Region (hg38): 2:96184859-96208827
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epilepsy, familial adult myoclonic, 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 31664034 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STARD7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 2 | 0 |
Variants in STARD7
This is a list of pathogenic ClinVar variants found in the STARD7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-96186746-C-T | not specified | Likely benign (May 08, 2023) | ||
2-96186798-C-A | Uncertain significance (-) | |||
2-96186885-T-C | not specified | Uncertain significance (Aug 20, 2024) | ||
2-96186906-C-G | not specified | Uncertain significance (Jun 14, 2022) | ||
2-96187232-A-G | not specified | Uncertain significance (Nov 06, 2023) | ||
2-96187246-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
2-96187258-G-A | not specified | Uncertain significance (Oct 03, 2024) | ||
2-96192373-T-A | not specified | Uncertain significance (Nov 15, 2024) | ||
2-96192391-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
2-96192392-G-A | not specified | Uncertain significance (May 30, 2023) | ||
2-96192399-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
2-96192415-GA-G | STARD7-related disorder | Uncertain significance (Nov 16, 2023) | ||
2-96192428-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
2-96193092-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
2-96193156-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
2-96193280-T-A | not specified | Uncertain significance (Apr 11, 2023) | ||
2-96193333-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
2-96194965-T-C | Epilepsy, familial adult myoclonic, 2 • not specified | Uncertain significance (Apr 04, 2023) | ||
2-96194999-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
2-96195376-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
2-96195387-C-A | not specified | Uncertain significance (May 23, 2023) | ||
2-96195422-G-A | Epilepsy, familial adult myoclonic, 2 | Uncertain significance (Sep 26, 2021) | ||
2-96195427-T-C | not specified | Uncertain significance (Aug 11, 2024) | ||
2-96195430-T-C | not specified | Uncertain significance (Aug 31, 2022) | ||
2-96195479-G-A | Epilepsy, familial adult myoclonic, 2 • not specified | Uncertain significance (Oct 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STARD7 | protein_coding | protein_coding | ENST00000337288 | 8 | 23967 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.472 | 0.528 | 125584 | 0 | 9 | 125593 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.958 | 177 | 217 | 0.817 | 0.0000120 | 2392 |
Missense in Polyphen | 50 | 74.265 | 0.67326 | 804 | ||
Synonymous | -0.945 | 88 | 77.4 | 1.14 | 0.00000382 | 700 |
Loss of Function | 3.17 | 4 | 18.9 | 0.212 | 8.87e-7 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000551 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000451 | 0.0000441 |
Middle Eastern | 0.0000551 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a protective role in mucosal tissues by preventing exaggerated allergic responses. {ECO:0000250|UniProtKB:Q8R1R3}.;
- Pathway
- Metabolism of lipids;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.422
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.01
Haploinsufficiency Scores
- pHI
- 0.305
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.419
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stard7
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- phosphatidylcholine biosynthetic process;phospholipid transport
- Cellular component
- mitochondrial outer membrane
- Molecular function
- phospholipid transporter activity;lipid binding